| 2026-02-25 |
详情>>
内部人交易：
JOHNSON MICHAEL股份增加72689.00股
|
| 2026-02-18 |
详情>>
股本变动：
变动后总股本10336.56万股
|
| 2026-02-18 |
详情>>
业绩披露：
2025年年报每股收益2.22美元,归母净利润2.28亿美元,同比去年增长-10.22%
|
| 2026-02-18 |
财报披露：
美东时间 2026-02-18 盘后发布财报
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.39美元,归母净利润1.43亿美元,同比去年增长87.04%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.98美元,归母净利润9970.00万美元,同比去年增长243.79%
|
| 2025-04-30 |
详情>>
业绩披露：
2025年一季报每股收益0.50美元,归母净利润5040.00万美元,同比去年增长107.41%
|
| 2025-03-11 |
股东大会：
将于2025-04-23召开股东大会
会议内容 ▼▲
- 1.Elect each of the 11 director nominees named in the Proxy Statement to the Board of Directors to serve until the 2026 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2025.
|
| 2025-02-19 |
详情>>
业绩披露：
2024年年报每股收益2.53美元,归母净利润2.54亿美元,同比去年增长78.83%
|
| 2025-02-19 |
详情>>
业绩披露：
2022年年报每股收益3.26美元,归母净利润3.21亿美元,同比去年增长-28.15%
|
| 2024-10-30 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.33美元,归母净利润1.32亿美元,同比去年增长-50.54%
|
| 2024-10-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.76美元,归母净利润7640.00万美元,同比去年增长-42.12%
|
| 2024-07-31 |
详情>>
业绩披露：
2024年中报每股收益0.29美元,归母净利润2900.00万美元,同比去年增长-67.49%
|
| 2024-05-01 |
详情>>
业绩披露：
2024年一季报每股收益0.24美元,归母净利润2430.00万美元,同比去年增长-17.06%
|
| 2024-03-12 |
股东大会：
将于2024-04-25召开股东大会
会议内容 ▼▲
- 1.Elect each of the 10 director nominees named in the Proxy Statement to the Board of Directors to serve until the 2025 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Approve an amendment and restatement of the Company’s 2023 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan;
4.Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2024.
|
| 2024-02-14 |
详情>>
业绩披露：
2023年年报每股收益1.44美元,归母净利润1.42亿美元,同比去年增长-55.74%
|
| 2023-03-14 |
股东大会：
将于2023-04-26召开股东大会
会议内容 ▼▲
- 1.Elect each of the 10 director nominees named in the Proxy Statement to the Board of Directors to serve until the 2024 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Advise as to the frequency of shareholder advisory votes on compensation of the Company’s named executive officers;
4.Approve, as a special resolution, the name change of the Company from “Herbalife Nutrition Ltd.” to “Herbalife Ltd.”;
5.Approve the Company’s 2023 Stock Incentive Plan;
6.Ratify, on an advisory basis, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2023.
|
| 2022-03-15 |
股东大会：
将于2022-04-27召开股东大会
会议内容 ▼▲
- 1.Elect each of the 10 directors named in the Proxy Statement to the Board of Directors to serve until the 2023 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Ratify the appointment of the Company’s independent registered public accounting firm for fiscal year 2022.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-16 |
股东大会：
将于2021-04-28召开股东大会
会议内容 ▼▲
- 1.Elect the 9 directors named in the Proxy Statement to the Board of Directors to serve until the 2022 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Approve an amendment and restatement of the Company’s 2014 Stock Incentive Plan to increase the number of Common Shares available for issuance under such plan;
4.Ratify the appointment of the Company’s independent registered public accounting firm for fiscal year 2021.
|
| 2020-08-28 |
复牌提示：
2020-08-28 10:32:29 停牌，复牌日期 2020-08-28 10:37:38
|
| 2020-03-17 |
股东大会：
将于2020-04-29召开股东大会
会议内容 ▼▲
- 1.Elect the 13 directors named in the Proxy Statement to the Board of Directors to serve until the 2021 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Approve, as a special resolution, an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (the “Articles”) to eliminate the casting vote;
4.Approve, as a special resolution, an amendment to the Articles to require the approval of two-thirds of the members of the Board of Directors then in office to amend the Company’s Principles of Corporate Governance to make any changes to the responsibilities of the Chairman of the Board or the Lead Director as set forth therein;
5.Ratify the appointment of the Company’s independent registered public accounting firm for fiscal year 2020.
|
| 2019-03-12 |
股东大会：
将于2019-04-24召开股东大会
会议内容 ▼▲
- 1.Elect the 14 directors named in the Proxy Statement to the Board of Directors to serve until the 2020 annual general meeting of shareholders of the Company or until their successors are duly elected and qualified;
2.Approve, on an advisory basis, the compensation of the Company’s named executive officers;
3.Ratify the appointment of the Company’s independent registered public accounting firm for fiscal year 2019.
|
| 2018-03-13 |
股东大会：
将于2018-04-24召开股东大会
会议内容 ▼▲
- 1.Elect the 14 directors named in the Proxy Statement;
2.Approve, on an advisory basis, the Company’s executive compensation;
3.Approve, as a special resolution, the name change of the Company from “Herbalife Ltd.” to “Herbalife Nutrition Ltd.”;
4.Approve, as a special resolution, an amendment and restatement of the Company’s Amended and Restated Memorandum and Articles of Association in the form attached as Annex A;
5.Effect a two-for-one stock split of the Company’s Common Shares;
6.Ratify the appointment of the Company’s independent registered public accountants for fiscal 2018.
|
| 2018-02-28 |
详情>>
拆分方案：
每1.0000股拆分成2.0000股
|
| 2017-03-13 |
股东大会：
将于2017-04-27召开股东大会
会议内容 ▼▲
- 1. Elect the 13 directors named in the Proxy Statement;
2. Approve, on an advisory basis, the Company’s executive compensation;
3. Advise as to the frequency of shareholder advisory votes on the Company’s executive compensation;
4. Ratify the appointment of the Company’s independent registered public accountants for fiscal 2017.
|
| 2016-03-14 |
股东大会：
将于2016-04-28召开股东大会
会议内容 ▼▲
- 1. Elect the 13 directors named in the Proxy Statement;
2. Approve, on an advisory basis, the Company’s executive compensation;
3. Ratify the appointment of the Company’s independent registered public accountants for fiscal 2016;
4. Approve an amendment and restatement to the Company’s 2014 Stock Incentive Plan to, among other things, increase the number of Common Shares available for issuance under such plan;
5. Re-approve the performance goals under the Company’s Executive Incentive Plan for compliance with Section 162(m) of the Code.
|
| 2014-02-18 |
除权日：
美东时间 2014-02-28 每股派息0.30美元
|
| 2013-10-29 |
除权日：
美东时间 2013-11-07 每股派息0.30美元
|
| 2013-07-29 |
除权日：
美东时间 2013-08-09 每股派息0.30美元
|
| 2013-04-29 |
除权日：
美东时间 2013-05-10 每股派息0.30美元
|
| 2013-02-19 |
除权日：
美东时间 2013-03-01 每股派息0.30美元
|
| 2012-10-29 |
除权日：
美东时间 2012-11-09 每股派息0.30美元
|
| 2012-07-31 |
除权日：
美东时间 2012-08-10 每股派息0.30美元
|
| 2012-05-01 |
除权日：
美东时间 2012-05-11 每股派息0.30美元
|
| 2012-02-22 |
除权日：
美东时间 2012-03-05 每股派息0.30美元
|
| 2011-11-01 |
除权日：
美东时间 2011-11-09 每股派息0.20美元
|
| 2011-08-02 |
除权日：
美东时间 2011-08-11 每股派息0.20美元
|
| 2011-05-03 |
除权日：
美东时间 2011-05-20 每股派息0.20美元
|
| 2011-02-23 |
除权日：
美东时间 2011-03-04 每股派息0.25美元
|
| 2010-11-02 |
除权日：
美东时间 2010-11-10 每股派息0.25美元
|
| 2010-08-03 |
除权日：
美东时间 2010-08-10 每股派息0.25美元
|
| 2010-04-30 |
除权日：
美东时间 2010-05-06 每股派息0.20美元
|